AZN Astrazeneca: breztri is now available in US as first and only fixed-dose triple therapy for asthma patients 12 years of age and older
Story updates
01:39:13 PM UTC
SquawkNews
AstraZeneca’s Breztri Available In US As First And Only Fixed-Dose Triple Therapy For Asthma Patients +12 Years
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.